InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
May 08, 2024 07:30 ET
|
InflaRx N.V.
Virtual R&D event to be held on June 5, 2024 from 12:00 to 2:00 PM EDT – highlighting company plans for INF904 and the opportunity, the role of C5aR in chronic spontaneous urticaria (CSU) and...